Provided by Tiger Fintech (Singapore) Pte. Ltd.

10x Genomics, Inc.

9.42
+0.31003.40%
Post-market: 9.520.0982+1.04%19:29 EDT
Volume:5.03M
Turnover:47.99M
Market Cap:1.16B
PE:-7.27
High:9.83
Open:9.38
Low:9.21
Close:9.11
Loading ...

UBS Adjusts Price Target on 10x Genomics to $12 From $14, Maintains Neutral Rating

MT Newswires Live
·
13 May

Short Squeeze Could Be Giving Stocks a Boost -- Barrons.com

Dow Jones
·
13 May

10x Genomics Is Maintained at Sell by Goldman Sachs

Dow Jones
·
13 May

Stock Track | 10x Genomics Soars 9.75% in Pre-market as Canaccord Genuity Maintains Buy Rating

Stock Track
·
12 May

10x Genomics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
12 May

U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Comstock, Range Resources

Reuters
·
12 May

10x Genomics Is Maintained at Neutral by JP Morgan

Dow Jones
·
10 May

Stock Track | 10x Genomics Soars 13.56% Pre-market on Earnings Beat and CEO's Candid Remarks on Research Funding Challenges

Stock Track
·
09 May

10x Genomics Inc : JP Morgan Cuts Target Price to $9 From $12

THOMSON REUTERS
·
09 May

Stock Track | 10x Genomics Soars 5.10% Pre-market Following Earnings Beat and CEO's Comments on Research Funding Challenges

Stock Track
·
09 May

10x Genomics CEO Calls NIH The 'Foundational Jewel' Of Biomedical Progress, Says 40% To 50% Of Revenue Supported By Academic And Government Research Funding — Pulls Full Year Revenue Guidance

Benzinga
·
09 May

10X Genomics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

10x Genomics Q1 EPS $(0.28) Beats $(0.48) Estimate, Sales $154.88M Beat $132.45M Estimate

Benzinga
·
09 May

10x Genomics Rises 3.5% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
09 May

10x Genomics Reports 10% Revenue Increase in Q1 2025, Net Loss Reduced to $34.4 Million

Reuters
·
09 May

BRIEF-10X Genomics Q1 Revenue USD 154.9 Million Vs. IBES Estimate USD 132.5 Million

Reuters
·
09 May

10x Genomics Inc: Withdrawing Its Previously Issued Full Year Revenue Guidance

THOMSON REUTERS
·
09 May

10x Genomics Inc: Recently Implemented Reduction of About 8% of Global Workforce

THOMSON REUTERS
·
09 May

10x Genomics Inc: We Are Temporarily Moving to Quarterly Guidance Until We See Greater Visibility Return

THOMSON REUTERS
·
09 May

10x Genomics Inc Outlook Q2 Revenue $138 Mln to $142 Mln

THOMSON REUTERS
·
09 May